Ayurveda Herbal medicines and Sickle Cell anemia

Efficacy of Dadimadi Avaleha as an adjuvant in the management of Sickle Cell Anemia in children - A Randomized Controlled Clinical Trial - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/12/078129

Enrollment

120

Registered

2024-12-16

Start date

Unknown

Completion date

Unknown

Last updated

2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D570- Hb-SS disease with crisis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Prediagnosed cases of Sickle Cell Anemia Hb less than 6.5g/dl and more than 11.5g/dl Serum Bilirubin less than 3g/dl Patients with the signs and symptoms of SCA

Exclusion criteria

Exclusion criteria: Patients with impaired liver and renal function SCA associated with other systemic disorders like Diabetes Mellitus Hypothyroidism Known cases of Hemoglobinopathies other than Sickle Cell Anemia

Design outcomes

Primary

Measure	Time frame
Improvement in signs and symptoms of children suffering from Sickle Cell AnemiaTimepoint: 0 day 30 day 60 day 90 day	—

Secondary

Measure	Time frame
Enhancement in immune status along with Quality Of Life (QoL) of the children and reduction in episodes of crisisTimepoint: 0 day 30 day 60 day 90 day	—

Countries

India

Contacts

Public ContactDr Swapnil C Raskar

Parul Institute of Ayurved

neonatecare2024@gmail.com09726587013

Outcome results